| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/29/2002 | EP1208201A2 Compositions and methods for the treatment of immune related diseases |
| 05/29/2002 | EP1208196A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 05/29/2002 | EP1208191A1 13 human colon and colon cancer associated proteins |
| 05/29/2002 | EP1208103A2 Reverse-turn mimetics and methods relating thereto |
| 05/29/2002 | EP1208100A1 Selective antagonists of a2b adenosine receptors |
| 05/29/2002 | EP1208099A1 4,5-diaryloxazole compounds with prostaglandin i2 (pgi2) agonistic activity |
| 05/29/2002 | EP1208092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 05/29/2002 | EP1207894A1 A synergistic composition for the treatment of liver and liver associated ailments and a process for preparing the same |
| 05/29/2002 | EP1207881A1 Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 05/29/2002 | EP1207878A2 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 05/29/2002 | EP1207873A1 Methods of inhibiting osteoclast activity |
| 05/29/2002 | EP1207868A1 Pharmaceutical tramadol salts |
| 05/29/2002 | EP1207867A1 Oral pharmaceutical forms of administration with a delayed action |
| 05/29/2002 | EP1207866A1 Delayed-action form of administration containing tramadol saccharinate |
| 05/29/2002 | EP1207863A2 New uses for potassium channel openers, such as the treatment of epilepsy |
| 05/29/2002 | EP1207860A1 Controlled release pellet formulation |
| 05/29/2002 | EP1207858A1 Oral dosage forms |
| 05/29/2002 | EP1061812A4 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 05/29/2002 | EP0826311B1 Oral composition for animals |
| 05/29/2002 | DE10058663A1 Verwendung von Thienopyrimidinen Use of Thienopyrimidinen |
| 05/29/2002 | DE10058662A1 Verwendung von Pyrazolo[4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines |
| 05/29/2002 | DE10057976A1 Verfahren zur Herstellung von Pektinhydrolyseprodukten A process for producing pectin hydrolysis products |
| 05/29/2002 | CN1351666A Recombinant bacterial phytases and uses thereof |
| 05/29/2002 | CN1351656A Human liver progenitors |
| 05/29/2002 | CN1351614A Human antibodies that bind human IL-12 and methods for producing |
| 05/29/2002 | CN1351609A Low-molecular inhibitors of complement proteases |
| 05/29/2002 | CN1351604A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 05/29/2002 | CN1351602A New pharmaceutically active compounds |
| 05/29/2002 | CN1351601A Heterocyclic compounds binding chemotactic factor receptor |
| 05/29/2002 | CN1351599A Indole-type derivatives as inhibitors of P38 kinase |
| 05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
| 05/29/2002 | CN1351591A 抗炎吲哚衍生物 Indomethacin derivative |
| 05/29/2002 | CN1351496A Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk |
| 05/29/2002 | CN1351494A Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 05/29/2002 | CN1351490A Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 05/29/2002 | CN1351473A Composition |
| 05/29/2002 | CN1350869A Medicine for treating hepatitis B virus |
| 05/29/2002 | CN1350866A Oral liquid for treating hepatitis B |
| 05/29/2002 | CN1350864A Powdered medicine for taking care of brain health and removing wrinkles |
| 05/29/2002 | CN1350856A Ointment for treating gastrosis by fomentation |
| 05/29/2002 | CN1350854A Full-natural medicine for treating calculus |
| 05/29/2002 | CN1350853A Medicine for nourishing vital energy and blood and its preparing process |
| 05/29/2002 | CN1350851A Baoyuanqiangsheng Dan |
| 05/29/2002 | CN1350849A Application of oxymetrine in preparing medicine to treat liver fibrosis |
| 05/29/2002 | CN1350848A Application of oxymatrine in preparing medicine to treat viral hepatitis C |
| 05/29/2002 | CN1085548C Traditional Chinese medicinal prepns. for treating hepatitis B virus, and method for preparing same |
| 05/29/2002 | CN1085545C Instant health medicated gruel powder for preventing and treating gastropathy and its production process |
| 05/29/2002 | CN1085543C Oral liquid for treating stomach disease |
| 05/29/2002 | CN1085541C Chinese medicine for treating calculus hydrops of liver, gall and kidney (CN) |
| 05/29/2002 | CN1085533C Pilose antler-wood trog oil oral liquor and preparing method thereof |
| 05/28/2002 | US6395781 Reducing vascular diameter |
| 05/28/2002 | US6395767 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 05/28/2002 | US6395764 Nosal decongestion, respiratory system disorders |
| 05/28/2002 | US6395763 Antitumor, anticancer agents; immunosuppressant |
| 05/28/2002 | US6395754 Antiinflammatory agents, cardiovascular disorders, antipyretics |
| 05/28/2002 | US6395736 Compositions and methods for the treatment of anorectal disorders |
| 05/28/2002 | US6395732 Bactericides |
| 05/28/2002 | US6395722 Fatty acid derivatives of bile acids and bile acid derivatives |
| 05/28/2002 | US6395708 Method for preventing diarrhea |
| 05/28/2002 | US6395707 Methods of treatment utilizing variants of vascular endothelial cell growth factor |
| 05/28/2002 | US6395476 Evaluating long term outcome of viral disease infection; obtain sample, obtain viral nucleotide sequence from sample, screen sequences for presence of mutation in preferential codon, presence of mutation indicate more sever viral disease |
| 05/28/2002 | US6395308 For the treatment of asthma bronchiale, colitis ulcerosa, morbus crohn, diseases of the rheumatic type, and indications in which an increase of the lipoxygenase level occurs either by medicaments, other substances or diseases. |
| 05/28/2002 | US6395307 Forming a protective coating on gastrointestinal mucosal tissue for treating reflux oesophagitis, gastritis, dyspepsia or peptic ulceration |
| 05/28/2002 | US6395266 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 05/28/2002 | US6394812 Vivo induction for enhanced function of isolated hepatocytes |
| 05/28/2002 | CA2181377C Tetracyclic derivatives, process of preparation and use |
| 05/28/2002 | CA2118997C Benzimidazole derivatives, their preparation and use |
| 05/23/2002 | WO2002040700A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 05/23/2002 | WO2002040681A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
| 05/23/2002 | WO2002040486A2 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS |
| 05/23/2002 | WO2002040480A2 Crf receptor antagonists and methods relating thereto |
| 05/23/2002 | WO2002040479A1 Anti-helicobacterial agents |
| 05/23/2002 | WO2002040476A1 Pyridyl-substituted triazoles as tgf inhibitors |
| 05/23/2002 | WO2002040475A1 Bombesin receptor antagonists |
| 05/23/2002 | WO2002040469A1 Bombesin receptor antagonists |
| 05/23/2002 | WO2002040468A1 Compounds |
| 05/23/2002 | WO2002040466A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
| 05/23/2002 | WO2002040456A1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor |
| 05/23/2002 | WO2002040450A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/23/2002 | WO2002040051A1 Colostrum-based composition |
| 05/23/2002 | WO2002040045A2 Microspheres of pancreatic enzymes with high stability |
| 05/23/2002 | WO2002040025A1 Anti-inflammatory agents |
| 05/23/2002 | WO2002040005A2 Blockade of sodium channels by phenol derivatives |
| 05/23/2002 | WO2002039989A1 Novel use of combined 5-ht1a agonists and selective serotonin reuptake inhibitors |
| 05/23/2002 | WO2002039988A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 05/23/2002 | WO2002039980A2 Capsule of cellulose derivatives such as hpmc containing benzimidazole derivatives such as omeprazole |
| 05/23/2002 | WO2002039978A1 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 05/23/2002 | WO2002039879A2 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 05/23/2002 | WO2002039834A1 Nutritional composition for an immune condition |
| 05/23/2002 | WO2002015931A9 Immunologic method for the prevention of dental caries |
| 05/23/2002 | WO2001096603A3 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 05/23/2002 | WO2001092253A3 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 05/23/2002 | WO2001085116A3 Synergistic antiplaque/antigingivitis oral composition |
| 05/23/2002 | WO2001085115A3 High cleaning dentifrice |
| 05/23/2002 | WO2001083513A3 Antisense modulation of inhibitor of dna binding-1 expression |
| 05/23/2002 | WO2001081549A3 Hepatocyte lineage cells derived from pluripotent stem cells |
| 05/23/2002 | WO2001081340A3 Heterocycles that are inhibitors of impdh enzyme |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001078752A3 Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs |